AAAAAA
Results:
1-7
|
Results: 7
Authors:
SCHWINGHAMMER TL
Citation: Tl. Schwinghammer, A CASE IN POINT, American journal of health-system pharmacy, 54(20), 1997, pp. 2404-2405
Authors:
HASELBERGER MB
SCHWINGHAMMER TL
Citation: Mb. Haselberger et Tl. Schwinghammer, EFFICACY OF MESNA FOR PREVENTION OF HEMORRHAGIC CYSTITIS AFTER HIGH-DOSE CYCLOPHOSPHAMIDE THERAPY, The Annals of pharmacotherapy, 29(9), 1995, pp. 918-921
Authors:
SCHWINGHAMMER TL
BLOOM EJ
ROSENFELD CS
WILSON JW
PRZEPIORKA D
SHADDUCK RK
Citation: Tl. Schwinghammer et al., HIGH-DOSE CYCLOSPORINE AND CORTICOSTEROIDS FOR PROPHYLAXIS OF ACUTE AND CHRONIC GRAFT-VERSUS-HOST DISEASE, Bone marrow transplantation, 16(1), 1995, pp. 147-154
Authors:
SCHWINGHAMMER TL
Citation: Tl. Schwinghammer, SAFETY, PHARMACOKINETICS, AND PHARMACODYNAMICS OF HIGH-DOSE ETOPOSIDE, Journal of clinical oncology, 12(12), 1994, pp. 2768-2768
Authors:
SCHWINGHAMMER TL
WIGGINS LE
BURGUNDER MR
MICHELL TE
BAILEY WL
Citation: Tl. Schwinghammer et al., ADVERSE REACTIONS RELATED TO IV INFUSION OF HIGH-DOSE CYCLOPHOSPHAMIDE IN BONE-MARROW TRANSPLANT PATIENTS, American journal of hospital pharmacy, 51(19), 1994, pp. 2419-2421
Authors:
SCHWINGHAMMER TL
FLEMING RA
ROSENFELD CS
PRZEPIORKA D
SHADDUCK RK
BLOOM EJ
STEWART CF
Citation: Tl. Schwinghammer et al., DISPOSITION OF TOTAL AND UNBOUND ETOPOSIDE FOLLOWING HIGH-DOSE THERAPY, Cancer chemotherapy and pharmacology, 32(4), 1993, pp. 273-278
Authors:
SCHWINGHAMMER TL
BLOOM EJ
Citation: Tl. Schwinghammer et Ej. Bloom, PHARMACOLOGICAL PROPHYLAXIS OF ACUTE GRAFT-VERSUS-HOST DISEASE AFTER ALLOGENEIC MARROW TRANSPLANTATION, Clinical pharmacy, 12(10), 1993, pp. 736-761
Risultati:
1-7
|